Neuropathology of FMR1-premutation carriers presenting with dementia and neuropsychiatric symptoms.
Neuropathology of FMR1-premutation carriers presenting with dementia and neuropsychiatric symptoms.
复制标题
表现为痴呆和神经精神症状的FMR1前突变携带者的神经病理学
DOI:
10.1093/braincomms/fcab007
复制
发表时间:
2021
影响因子:
4.8
通讯作者:
Hoozemans JJM
中科院分区:
文献类型:
--
作者:
Dijkstra AA;Haify SN;Verwey NA;Prins ND;van der Toorn EC;Rozemuller AJM;Bugiani M;den Dunnen WFA;Todd PK;Charlet-Berguerand N;Willemsen R;Hukema RK;Hoozemans JJM
CGG repeat expansions within the premutation range (55–200) of the FMR1 gene can lead to Fragile X-associated tremor/ataxia syndrome and Fragile X-associated neuropsychiatric disorders. These CGG repeats are translated into a toxic polyglycine-containing protein, FMRpolyG. Pathology of Fragile X-associated tremor/ataxia syndrome and Fragile X-associated neuropsychiatric disorders comprises FMRpolyG- and p62-positive intranuclear inclusions. Diagnosing a FMR1-premutation carrier remains challenging, as the clinical features overlap with other neurodegenerative diseases. Here, we describe two male cases with Fragile X-associated neuropsychiatric disorders-related symptoms and mild movement disturbances and novel pathological features that can attribute to the variable phenotype. Macroscopically, both donors did not show characteristic white matter lesions on MRI; however, vascular infarcts in cortical- and sub-cortical regions were identified. Immunohistochemistry analyses revealed a high number of FMRpolyG intranuclear inclusions throughout the brain, which were also positive for p62. Importantly, we identified a novel pathological vascular phenotype with inclusions present in pericytes and endothelial cells. Although these results need to be confirmed in more cases, we propose that these vascular lesions in the brain could contribute to the complex symptomology of FMR1-premutation carriers. Overall, our report suggests that Fragile X-associated tremor/ataxia syndrome and Fragile X-associated neuropsychiatric disorders may present diverse clinical involvements resembling other types of dementia, and in the absence of genetic testing, FMRpolyG can be used post-mortem to identify premutation carriers. FMR1-premutation carriers can present clinically with a range of symptoms, including neuropsychiatric symptoms. Pathologically, the nuclear inclusions are positive for FMRpolyG and in the donors discussed here, also present in the vasculature. This has not been described before and this finding possibly contributes to the complex phenotype.
登录
查看更多内容
影响因子:
16.2
作者:
Todd PK;Oh SY;Krans A;He F;Sellier C;Frazer M;Renoux AJ;Chen KC;Scaglione KM;Basrur V;Elenitoba-Johnson K;Vonsattel JP;Louis ED;Sutton MA;Taylor JP;Mills RE;Charlet-Berguerand N;Paulson HL
通讯作者:
Paulson HL
DOI:
10.1080/13854046.2016.1202239
发表时间:
2016-08
期刊:
The Clinical neuropsychologist
影响因子:
--
作者:
Robertson EE;Hall DA;McAsey AR;O'Keefe JA
通讯作者:
O'Keefe JA
影响因子:
2
作者:
Berry-Kravis, Elizabeth;Goetz, Christopher G.;Hagerman, Paul J.
通讯作者:
Hagerman, Paul J.
影响因子:
9.9
作者:
Hall, DA;Berry-Kravis, E;Leehey, MA
通讯作者:
Leehey, MA
影响因子:
8.6
作者:
Grigsby, Jim;Brega, Angela G.;Hagerman, Randi J.
通讯作者:
Hagerman, Randi J.